In-Hospital Mortality from Spondylodiscitis: Insights from a Single-Center Retrospective Study
Journal of Clinical Medicine · 22.11.2023 · 12 (23) · 7228
DOI: 10.3390/jcm12237228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.11.2023. Verfasst von Ann-Kathrin Joerger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Klinikum Rechts der Isar, Technical University Munich, 81675 Munich, Germany. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(1)
Background
There is a marked proportion of spondylodiscitis patients who die during the early stage of the disease despite the applied therapy. This study investigates this early mortality and explores the associated risk factors. (2)
Methods
We conducted a retrospective analysis of spondylodiscitis patients treated at our Level I spine center between 1 January 2018 and 31 December 2022. (3)
Results
Among 430 patients, 32 (7.4%) died during their hospital stay, with a median time of 28.5 days (range: 2.0–84.0 days). Six of these patients (18.75%) did not undergo surgery due to dire clinical conditions or death prior to scheduled surgery. Identified causes of in-hospital death included multiorgan failure (n = 15), acute bone marrow failure (2), cardiac failure (4), liver failure (2), acute respiratory failure (2), acute renal failure (1), and concomitant oncological disease (1). In a simple logistic regression analysis, advanced age (p = 0.0006), diabetes mellitus (p = 0.0002), previous steroid medication (p = 0.0279), Charlson Comorbidity Index (p < 0.0001), and GFR level at admission (p = 0.0008) were significant risk factors for in-hospital death. In a multiple logistic regression analysis, advanced age (p = 0.0038), diabetes mellitus (p = 0.0002), and previous steroid medication (p = 0.0281) remained significant. (4)
Conclusions
Despite immediate treatment, a subset of spondylodiscitis patients experience early mortality. Particular attention should be given to elderly patients and those with diabetes or a history of steroid medication, as they face an elevated risk of a rapidly progressing and fatal disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Klinikum Rechts der Isar, Technical University Munich, 81675 Munich, Germany.
ORCID-Profile: Ann-Kathrin Joerger, Bernhard Meyer, Maria Wostrack
Zitieren
APA
Joerger, A. K., Albrecht, C., Lange, N., Meyer, B., & Wostrack, M. (2023). In-Hospital Mortality from Spondylodiscitis: Insights from a Single-Center Retrospective Study. Journal of Clinical Medicine, 12(23), 7228. https://doi.org/10.3390/jcm12237228
Vancouver
Joerger AK, Albrecht C, Lange N, Meyer B, Wostrack M. In-Hospital Mortality from Spondylodiscitis: Insights from a Single-Center Retrospective Study. Journal of Clinical Medicine. 2023;12(23):7228. doi:10.3390/jcm12237228
BibTeX
@article{Joerger2023,
author = {Joerger, Ann-Kathrin and Albrecht, Carolin and Lange, Nicole and Meyer, Bernhard and Wostrack, Maria},
title = {In-Hospital Mortality from Spondylodiscitis: Insights from a Single-Center Retrospective Study},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {23},
pages = {7228},
doi = {10.3390/jcm12237228}
}
EUVIMED